Cargando…

Protective Effects of Aspirin from Cardiac Hypertrophy and Oxidative Stress in Cardiomyopathic Hamsters

Objective. To evaluate the capacity of chronic ASA therapy to prevent cardiac alterations and increased oxidative stress in cardiomyopathic hamsters. Methods and Results. Male Syrian cardiomyopathic and age-matched inbred control hamsters received ASA orally from the age of 60 days. Animals were sac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Rong, Yin, David, Sadekova, Nataliya, Deschepper, Christian F., de Champlain, Jacques, Girouard, Helene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399583/ https://www.ncbi.nlm.nih.gov/pubmed/22829962 http://dx.doi.org/10.1155/2012/761710

Ejemplares similares

Modulation of Vascular ACE by Oxidative Stress in Young Syrian Cardiomyopathic Hamsters: Therapeutic Implications
por: Cruz, Nildris, et al.
Publicado: (2016)

Carvedilol-Afforded Protection against Daunorubicin-Induced Cardiomyopathic Rats In Vivo: Effects on Cardiac Fibrosis and Hypertrophy
por: Arozal, Wawaimuli, et al.
Publicado: (2011)

The complex contribution of NOS interneurons in the physiology of cerebrovascular regulation
por: Duchemin, Sonia, et al.
Publicado: (2012)

Carotid Calcification in Mice: A New Model to Study the Effects of Arterial Stiffness on the Brain
por: Sadekova, Nataliya, et al.
Publicado: (2013)

The Protective Effect of Aspirin against Myocardial Hypertrophy in Rats
por: Wu, Xiaolong, et al.
Publicado: (2021)

The effect of myosin RLC phosphorylation in normal and cardiomyopathic mouse hearts
por: Muthu, Priya, et al.
Publicado: (2012)

Effects of Cholinergic Stimulation with Pyridostigmine Bromide on Chronic Chagasic Cardiomyopathic Mice
por: de Cuba, Marília Beatriz, et al.
Publicado: (2014)

Cardiomyopathic troponin mutations predominantly occur at its interface with actin and tropomyosin
por: Tobacman, Larry S., et al.
Publicado: (2021)

A hypertrophic and dilated cardiomyopathic sudden cardiac death case; de novo mutations in TTN and SGCD genes
por: Baydar, Çetin Lütfi, et al.
Publicado: (2016)

Structural and protein interaction effects of hypertrophic and dilated cardiomyopathic mutations in alpha-tropomyosin
por: Chang, Audrey N., et al.
Publicado: (2014)

Regional rotation of the left ventricle in healthy and cardiomyopathic subjects measured with radial myocardial tagging
por: Kaveh, Razieh, et al.
Publicado: (2014)

BH4 activates CaMKK2 and rescues the cardiomyopathic phenotype in rodent models of diabetes
por: Kim, Hyoung Kyu, et al.
Publicado: (2020)

Myocardial Stiffness Evaluation Using Noninvasive Shear Wave Imaging in Healthy and Hypertrophic Cardiomyopathic Adults
por: Villemain, Olivier, et al.
Publicado: (2019)

Cardiomyopathic mutations in essential light chain reveal mechanisms regulating the super relaxed state of myosin
por: Sitbon, Yoel H., et al.
Publicado: (2021)

Optical ventricular cardioversion by local optogenetic targeting and LED implantation in a cardiomyopathic rat model
por: Nyns, Emile C A, et al.
Publicado: (2021)

Short-Communication: Short-Term Treatment with Taurine Prevents the Development of Cardiac Hypertrophy and Early Death in Hereditary Cardiomyopathy of the Hamster and Is Sex-Dependent
por: Bkaily, Ghassan, et al.
Publicado: (2022)

Letter to the editor regarding the article “A case of hypertrophic and dilated cardiomyopathic sudden cardiac death: de novo mutation in TTN and SGCD genes”
por: Ergören, Mahmut Çerkez, et al.
Publicado: (2017)

An mRNA assay system demonstrates proteasomal-specific degradation contributes to cardiomyopathic phospholamban null mutation
por: Rohner, Eduarde, et al.
Publicado: (2021)

Longitudinal observations of progressive cardiac dysfunction in a cardiomyopathic animal model by self-gated cine imaging based on 11.7-T magnetic resonance imaging
por: Saito, Shigeyoshi, et al.
Publicado: (2017)

H(2)S-Releasing Aspirin Protects against Aspirin-Induced Gastric Injury via Reducing Oxidative Stress
por: Liu, Lei, et al.
Publicado: (2012)

Neurovascular Coupling in Hypertension Is Impaired by IL-17A through Oxidative Stress
por: Youwakim, Jessica, et al.
Publicado: (2023)

Proof of Principle that Molecular Modeling Followed by a Biophysical Experiment Can Develop Small Molecules that Restore Function to the Cardiac Thin Filament in the Presence of Cardiomyopathic Mutations
por: Szatkowski, Lukasz, et al.
Publicado: (2019)

Inhibition of Gene Expression of Organic Cation/Carnitine Transporter and Antioxidant Enzymes in Oxazaphosphorines-Induced Acute Cardiomyopathic Rat Models
por: Sayed-Ahmed, Mohamed M., et al.
Publicado: (2012)

Ameliorate Effects of Li-Fu Formula on IL-6-Mediated Cardiac Hypertrophy in Hamsters Fed with a Hyper-Cholesterol Diet
por: Cheng, Yi-Chang, et al.
Publicado: (2011)

Mid-wall fibrosis on delayed enhancement CMR - a marker for adverse left ventricular chamber remodeling independent of cardiomyopathic etiology
por: Kim, Jiwon, et al.
Publicado: (2014)

Gain-of-function cardiomyopathic mutations in RBM20 rewire splicing regulation and re-distribute ribonucleoprotein granules within processing bodies
por: Fenix, Aidan M., et al.
Publicado: (2021)

Cardiac Hypertrophy
por: DaCosta,
Publicado: (1891)

Oxidative Stress as A Mechanism for Functional Alterations in Cardiac Hypertrophy and Heart Failure
por: Shah, Anureet K., et al.
Publicado: (2021)

Downregulation of amphiregulin improves cardiac hypertrophy via attenuating oxidative stress and apoptosis
por: Ji, Mingyue, et al.
Publicado: (2022)

Slowing Heart Rate Protects Against Pathological Cardiac Hypertrophy
por: Sebastian, Sonia, et al.
Publicado: (2022)

Beta3-Adrenergic Receptor Activation Alleviates Cardiac Dysfunction in Cardiac Hypertrophy by Regulating Oxidative Stress
por: Zhang, Mingming, et al.
Publicado: (2021)

Thrombosis and Aspirin: Clinical Aspect, Aspirin in Cardiology, Aspirin in Neurology, and Pharmacology of Aspirin
por: Doutremepuich, Christian
Publicado: (2012)

Protective Effects of Thyroid Hormone Deprivation on Progression of Maladaptive Cardiac Hypertrophy and Heart Failure
por: Kerp, Helena, et al.
Publicado: (2021)

Choline Protects Against Cardiac Hypertrophy Induced by Increased After-load
por: Zhao, Yilei, et al.
Publicado: (2013)

SIRT2 inhibition protects against cardiac hypertrophy and ischemic injury
por: Yang, Xiaoyan, et al.
Publicado: (2023)

Cardiac hypertrophy at autopsy
por: Basso, Cristina, et al.
Publicado: (2021)

Cardiac Hypertrophy and Dilatation
por: Davis, M. T.
Publicado: (1915)

Epigallocatechin-3-Gallate Accelerates Relaxation and Ca(2+) Transient Decay and Desensitizes Myofilaments in Healthy and Mybpc3-Targeted Knock-in Cardiomyopathic Mice
por: Friedrich, Felix W., et al.
Publicado: (2016)

CARDIOMYOPATHIC GENE MUTATIONS ALTER ACE2 EXPRESSION AND INFECTIVITY OF SARS-COV-2 IN HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES
por: Kontorovich, Amy, et al.
Publicado: (2021)

UPLC-Q-TOF/MS-based metabonomic studies on the intervention effects of aspirin eugenol ester in atherosclerosis hamsters
por: Ma, Ning, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0idc7jcd06e4hfmt8c6dngpe0b